How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

126,027 results for

Review of Systems

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

125281. Scavenging system developed for the Magill anesthetic circuit for use in the dental office. Full Text available with Trip Pro

was developed which fulfills the requirements of both general dentists as well as those administering general anesthesia. This paper describes this system and its adaptation to the commonly used Magill circuit. It also briefly reviews the factors involved in potential toxicity caused by long term exposure to nitrous oxide and halothane. (...) Scavenging system developed for the Magill anesthetic circuit for use in the dental office. Numerous potential problems have been associated with long term or occupational exposure to both nitrous oxide and halothane. Despite the lack of firmly established cause-and-effect relationships, particularly in humans, it would seem prudent to use techniques that minimize operator exposure. With this in mind, a scavenging system for use in both conscious sedation and general anesthetic techniques

1990 Anesthesia progress

125282. Outcome and survival in systemic lupus erythematosus. Full Text available with Trip Pro

Outcome and survival in systemic lupus erythematosus. 2662916 1989 08 03 2018 11 13 0003-4967 48 6 1989 Jun Annals of the rheumatic diseases Ann. Rheum. Dis. Outcome and survival in systemic lupus erythematosus. 443-5 Bresnihan B B Department of Rheumatology, St Vincent's Hospital, Elm Park, Dublin. eng Journal Article Review England Ann Rheum Dis 0372355 0003-4967 IM Humans Lupus Erythematosus, Systemic drug therapy mortality Prognosis 11 1989 6 1 1989 6 1 0 1 1989 6 1 0 0 ppublish 2662916

1989 Annals of the Rheumatic Diseases

125283. Acute transverse myelopathy complicating systemic lupus erythematosus. Full Text available with Trip Pro

Acute transverse myelopathy complicating systemic lupus erythematosus. A sixteen year old girl with systemic lupus erythematosus developed acute transverse myelopathy. She was treated with high dose steroids, cyclophosphamide, and plasma exchange and regained partial neurological function. Previous descriptions of transverse myelopathy complicating systemic lupus erythematosus are reviewed, with particular reference to the efficacy of high dose steroid treatment.

1989 Annals of the Rheumatic Diseases

125284. Biochemistry of the plasmin system Full Text available with Trip Pro

Biochemistry of the plasmin system 6448871 1981 01 26 2018 11 13 0144-0330 14 1980 Journal of clinical pathology. Supplement (Royal College of Pathologists) J Clin Pathol Suppl (R Coll Pathol) Biochemistry of the plasmin system. 5-9 Ogston D D eng Journal Article Review England J Clin Pathol Suppl (R Coll Pathol) 8300543 0144-0330 9001-91-6 Plasminogen EC 3.4.21.- Plasminogen Activators EC 3.4.21.7 Fibrinolysin K3Z4F929H6 Lysine IM Chemical Phenomena Chemistry Enzyme Activation Fibrinolysin

1980 Journal of Clinical Pathology. Supplement (Royal College of Pathologists).

125285. Pneumococcal epiglottitis in systemic lupus erythematosus on high-dose corticosteroids. Full Text available with Trip Pro

Pneumococcal epiglottitis in systemic lupus erythematosus on high-dose corticosteroids. A patient with systemic lupus erythematosus who developed pneumococcal epiglottitis is described and the literature reviewed. This infection is extremely rare in adults, and only 10 cases, none of them with SLE, have so far been reported. Epiglottitis is usually caused by Haemophilus influenzae. However, in immunocompromised hosts the probability of Streptococcus pneumoniae as the infecting agent

1982 Annals of the Rheumatic Diseases

125286. Insidious bilateral infrapatellar tendon rupture in a patient with systemic lupus erythematosus. Full Text available with Trip Pro

Insidious bilateral infrapatellar tendon rupture in a patient with systemic lupus erythematosus. A patient with systemic lupus erythematosus developed insidious bilateral infrapatellar tendon rupture initially diagnosed as steroid myopathy. Simultaneous loss of extension at the knee due to quadriceps or infrapatellar tendon ruptures is reviewed.

1980 Annals of the Rheumatic Diseases

125287. A model for sensory adaptations of the visual system in squint. Full Text available with Trip Pro

A model for sensory adaptations of the visual system in squint. Sensory adaptations to squint are considered in the light of present knowledge of the visual sensory system. A model to assist our understanding of the clinical presentation of sensory adaptation is proposed. Suppression and abnormal correspondence are considered as anomalies of different parts of the sensory system, and the interplay of these adaptations is reviewed.

1980 The British journal of ophthalmology

125288. Engelmann's disease of bone--a systemic disorder? Full Text available with Trip Pro

Engelmann's disease of bone--a systemic disorder? A patient with Engelmann's disease of bone (progressive diaphyseal dysplasia) also suffered from Raynaud's phenomenon, multiple nail fold infarcts, anaemia, leucopenia, hepatosplenomegaly, and a raised erythrocyte sedimentation rate. Her mother, who also had this inherited bone disease, was known to have Raynaud's phenomenon, necrotising vasculitis, and digital gangrene. Review of other published cases of Engelmann's disease indicates that some (...) of these features are not uncommon. It is argued that Engelmann's disease is not primarily a metabolic bone disease but may be a systemic disorder which might be included within the spectrum of the inflammatory connective tissue diseases. The beneficial effects of steroid treatment on both skeletal and systemic features are compatible with this view.

1982 Annals of the Rheumatic Diseases

125289. Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. Full Text available with Trip Pro

Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. 6997723 1980 11 25 2018 11 13 0146-0749 44 1 1980 Mar Microbiological reviews Microbiol. Rev. Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. 83-105 Foster J W JW Moat A G AG eng Journal Article Review United States Microbiol Rev 7806086 0146-0749 0 Nucleotides 0 Pyridines 0U46U6E8UK NAD 53-59-8 NADP IM Azotobacter metabolism

1980 Microbiological reviews

125290. Parallel processing in the nervous system: Evidence from sensory maps Full Text available with Trip Pro

Parallel processing in the nervous system: Evidence from sensory maps 9448262 1998 03 11 2018 11 13 0027-8424 95 3 1998 Feb 03 Proceedings of the National Academy of Sciences of the United States of America Proc. Natl. Acad. Sci. U.S.A. Parallel processing in the nervous system: evidence from sensory maps. 933-4 Young E D ED Department of Biomedical Engineering, The Johns Hopkins University, Baltimore, MD 21205, USA. eyoung@bme.jhu.edu eng Comment Journal Article Review United States Proc Natl

1998 Proceedings of the National Academy of Sciences of the United States of America

125291. Can drug delivery systems deliver value in the new pharmaceutical marketplace? Full Text available with Trip Pro

Can drug delivery systems deliver value in the new pharmaceutical marketplace? 9384456 1998 02 11 2009 10 02 0306-5251 44 5 1997 Nov British journal of clinical pharmacology Br J Clin Pharmacol Can drug delivery systems deliver value in the new pharmaceutical marketplace? 413-9 Urquhart J J Department of Epidemiology, Maastricht University, The Netherlands. eng Journal Article Review England Br J Clin Pharmacol 7503323 0306-5251 0 Delayed-Action Preparations IM Chemistry, Pharmaceutical (...) economics Delayed-Action Preparations Drug Delivery Systems economics Humans 39 1998 2 12 1998 2 12 0 1 1998 2 12 0 0 ppublish 9384456 PMC2042868

1997 British journal of clinical pharmacology

125292. The replication licensing system Full Text available with Trip Pro

. The origin recognition complex (ORC) and Cdc6/Cdc18 are needed on chromatin before the licensing reaction can take place, although they are not themselves components of the licensing system. Cell cycle events and cyclin-dependent protein kinases (Cdks) also seem to be involved in controlling the licensing system to ensure once per cell cycle DNA replication. The subject of this review is to detail our current understanding of the licensing system and the way that it interacts with other components (...) The replication licensing system The replication licensing system acts to ensure that no section of the genome is replicated more than once in a single cell cycle. Experiments using Xenopus egg extracts have revealed that the licensing system consists of two components, named RLF-M and RLF-B. Whereas the function of RLF-B is still unclear, RLF-M has been shown to consist of all six members of the MCM/P1 family proteins, which appear to be the structural component of the licensing system

1998 Biological chemistry

125293. Plant science in lac: A continuation of using tools from Escherichia coli in studying gene function in heterologous systems Full Text available with Trip Pro

Plant science in lac: A continuation of using tools from Escherichia coli in studying gene function in heterologous systems 9419333 1998 02 18 2018 11 13 0027-8424 95 1 1998 Jan 06 Proceedings of the National Academy of Sciences of the United States of America Proc. Natl. Acad. Sci. U.S.A. Plant science in lac: A continuation of using tools from Escherichia coli in studying gene function in heterologous systems. 93-4 Messing J J Waksman Institute, 190 Frelinghuysen Road, Rutgers University (...) , Piscataway, NJ 08854-8020, USA. messing@mbcl.rutgers.edu eng Journal Article Review United States Proc Natl Acad Sci U S A 7505876 0027-8424 IM Escherichia coli genetics Genetic Engineering Lac Operon Plants genetics 11 1998 2 21 1998 2 21 0 1 1998 2 21 0 0 ppublish 9419333 PMC34199 Nature. 1974 Jun 7;249(457):561-3 4599764 Plant J. 1992 May;2(3):397-404 1303802 Mol Biotechnol. 1996 Feb;5(1):39-47 8853015 Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):376-81 9419383 Science. 1984 Nov 16;226(4676):792-801

1998 Proceedings of the National Academy of Sciences of the United States of America

125294. Epidemiology of systemic lupus erythematosus. Full Text available with Trip Pro

Epidemiology of systemic lupus erythematosus. 1485809 1993 02 18 2018 11 13 0003-4967 51 12 1992 Dec Annals of the rheumatic diseases Ann. Rheum. Dis. Epidemiology of systemic lupus erythematosus. 1292-4 Hopkinson N N Department of Rheumatology, Derbyshire Royal Infirmary, United Kingdom. eng Journal Article Review England Ann Rheum Dis 0372355 0003-4967 IM Adolescent Adult Aged Asia ethnology Female Humans Incidence Lupus Erythematosus, Systemic epidemiology Male Middle Aged Prevalence United

1992 Annals of the Rheumatic Diseases

125295. Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria. Full Text available with Trip Pro

Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria. Numerous gram-negative and gram-positive bacteria take up carbohydrates through the phosphoenolpyruvate (PEP):carbohydrate phosphotransferase system (PTS). This system transports and phosphorylates carbohydrates at the expense of PEP and is the subject of this review. The PTS consists of two general proteins, enzyme I and HPr, and a number of carbohydrate-specific enzymes, the enzymes II. PTS proteins are phosphoproteins (...) repressor and activator proteins, other types of regulation, such as antitermination, have been observed in some PTSs. Apart from their role in carbohydrate transport, PTS proteins are involved in chemotaxis toward PTS carbohydrates. Furthermore, the IIAGlc protein, part of the glucose-specific PTS, is a central regulatory protein which in its nonphosphorylated form can bind to and inhibit several non-PTS uptake systems and thus prevent entry of inducers. In its phosphorylated form, P-IIAGlc is involved

1993 Microbiological reviews

125296. Lymph node hyalinisation in rheumatoid arthritis and systemic sclerosis. Full Text available with Trip Pro

Lymph node hyalinisation in rheumatoid arthritis and systemic sclerosis. To review the histological features of lymph nodes excised from seven patients with rheumatoid arthritis and one with systemic sclerosis.Lymph nodes excised from seven patients with rheumatoid arthritis and one patient with systemic sclerosis over a 10 year period were examined using the stains haematoxylin and eosin, periodic acid Schiff (PAS), Masson-trichrome, and Congo red for amyloid.Of the seven nodes examined from (...) calcified. In the seventh patient with rheumatoid arthritis the excised lymph node was almost totally replaced by similar PAS positive hyaline material which showed extensive areas of calcification. The lymph node removed from the patient with systemic sclerosis similarly showed almost total replacement by PAS positive hyaline material.In all cases the nodes contained PAS positive extracellular hyaline material to a greater or lesser degree. The lymph nodes from two of the patients with rheumatoid

1994 Journal of Clinical Pathology

125297. The skin immune system and psoriasis. Full Text available with Trip Pro

The skin immune system and psoriasis. 8443957 1993 04 05 2018 11 13 0009-9104 91 3 1993 Mar Clinical and experimental immunology Clin. Exp. Immunol. The skin immune system and psoriasis. 343-5 Breathnach S M SM eng Comment Editorial Review England Clin Exp Immunol 0057202 0009-9104 IM Clin Exp Immunol. 1993 Mar;91(3):346-50 8443958 Endothelium, Vascular metabolism Humans Immune System Lymphocytes metabolism Psoriasis immunology Skin immunology 35 1993 3 1 1993 3 1 0 1 1993 3 1 0 0 ppublish

1993 Clinical and experimental immunology

125298. Insights into the role of the immune system in prion diseases. Full Text available with Trip Pro

Insights into the role of the immune system in prion diseases. 7904753 1994 02 22 2018 11 13 0027-8424 91 2 1994 Jan 18 Proceedings of the National Academy of Sciences of the United States of America Proc. Natl. Acad. Sci. U.S.A. Insights into the role of the immune system in prion diseases. 429-32 Berg L J LJ Department of Cellular and Developmental Biology, Harvard University, Cambridge, MA 02138. eng Journal Article Review United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 PrPSc

1994 Proceedings of the National Academy of Sciences of the United States of America

125299. Restrictions on the use of antigenic peptides by the immune system. Full Text available with Trip Pro

Restrictions on the use of antigenic peptides by the immune system. 8387195 1993 06 01 2018 11 13 0027-8424 90 9 1993 May 01 Proceedings of the National Academy of Sciences of the United States of America Proc. Natl. Acad. Sci. U.S.A. Restrictions on the use of antigenic peptides by the immune system. 3777-9 Howard J C JC Department of Immunology, Agricultural and Food Research Council Babraham Institute, Cambridge, United Kingdom. eng Journal Article Review United States Proc Natl Acad Sci U S (...) A 7505876 0027-8424 0 Antigens, Differentiation, T-Lymphocyte 0 Histocompatibility Antigens Class I 0 Receptors, Antigen, T-Cell 0 Tumor Necrosis Factor Receptor Superfamily, Member 7 IM Animals Antigens, Differentiation, T-Lymphocyte genetics Histocompatibility Antigens Class I biosynthesis genetics Humans Immune System immunology Major Histocompatibility Complex Models, Biological Polymorphism, Genetic Receptors, Antigen, T-Cell genetics Tumor Necrosis Factor Receptor Superfamily, Member 7 20 1993 5 1

1993 Proceedings of the National Academy of Sciences of the United States of America

125300. Selective C4 deficiency, systemic lupus erythematosus, and Whipple's disease. Full Text available with Trip Pro

Selective C4 deficiency, systemic lupus erythematosus, and Whipple's disease. A 45-year-old female with selective deficiency of C4 and systemic lupus erythematosus developed puzzling gastrointestinal and systemic symptoms in the last 6 months of her life. Extensive investigation of the gastrointestinal tract did not yield any diagnosis, and the patient died shortly afterwards. Autopsy revealed evidence of a typical Whipple's disease of the jejunum and lymph nodes. This association has not been (...) previously described. The disease is reviewed with emphasis on its being an opportunistic infection in an immunosuppressed host with a complement deficiency and SLE.

1984 Annals of the Rheumatic Diseases

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>